FeesSafety
Pluang+

ISS A/S continues share buyback, repurchasing 7.69 million shares worth DKK 2.05 billion

Company Fundamentals
09 Nov 2026, 15:59 WIB
Na
View Source
Neutral
ISS A/S continues share buyback, repurchasing 7.69 million shares worth DKK 2.05 billion

ISS A/S is actively executing its share buyback program announced in February 2026, aiming to redistribute excess cash to shareholders and reduce share capital. As of early November 2026, the company has repurchased approximately 7.69 million shares at an average price of DKK 267.03, totaling about DKK 2.05 billion. This buyback is part of a 12-month plan with a maximum budget of DKK 3.1 billion, including funds for share-based incentive programs. Following these transactions, ISS holds 7.44 million treasury shares, representing 4.65% of its total share capital.

ISS A/S share buyback program has repurchased about 7.69 million shares, representing 4.65% of its total share capital as of early November 2026. For readers following the Industrials sector, here is Pluang's market snapshot as of Nov 09, 2026 16:12 WIB: out of 135 priced US Industrials stocks, 75 rose and 33 fell. Notable movers include FLUX at USD 0.32 (+2.56%), ENVX at USD 2.69 (-2.54%), and HAFN at USD 9.60 (+2.45%).

More News

AL Sydbank buys back 30,000 shares in week 45, continuing its DKK 1.1bn buyback program.

AL Sydbank buys back 30,000 shares in week 45, continuing its DKK 1.1bn buyback program.

AL Sydbank A/S executed transactions to buy back 30,000 shares during week 45 as part of its ongoing share buyback program announced in February 2026, which totals DKK 1.1 billion. The program started in March 2026 and will conclude by January 2027, ...

Company Fundamentals
Neutral
22 minutes ago
AL Sydbank buys back shares worth 21.76 million DKK in week 45 as part of a 1.1 billion DKK program.

AL Sydbank buys back shares worth 21.76 million DKK in week 45 as part of a 1.1 billion DKK program.

AL Sydbank A/S continued its share buyback program in week 45, purchasing 30,000 shares at an average price of around 725 DKK, totaling approximately 21.76 million DKK. The buyback program, announced in February 2026 and running until January 2027, a...

Company Fundamentals
Neutral
22 minutes ago
Oculis to host R&D Day showcasing late-stage pipeline for dry eye and neuro-ophthalmology treatments

Oculis to host R&D Day showcasing late-stage pipeline for dry eye and neuro-ophthalmology treatments

Oculis Holding AG announced an in-person and virtual R&D Day on December 8, 2026, to highlight key clinical developments in its late-stage pipeline, including Licaminlimab for dry eye disease and Privosegtor for neuro-ophthalmology and neurology. The...

Market News
Bullish
2 hours ago
Oculis announces R&D Day to showcase late-stage eye disease drug developments Licaminlimab and Privosegtor.

Oculis announces R&D Day to showcase late-stage eye disease drug developments Licaminlimab and Privosegtor.

Oculis Holding AG will hold a Research & Development Day on December 8, 2026, to present key clinical progress on its late-stage drug candidates Licaminlimab for dry eye disease and Privosegtor for neuro-ophthalmic conditions including optic neuritis...

Company Fundamentals
Bullish
2 hours ago
DNO ASA's offer for Capricorn Energy plc lapses, ending the acquisition attempt.

DNO ASA's offer for Capricorn Energy plc lapses, ending the acquisition attempt.

DNO ASA announced that its offer to acquire Capricorn Energy plc has lapsed as of November 9, 2026. This means the acquisition attempt will not proceed, impacting DNO's expansion plans in the oil and gas sector. Investors should monitor DNO's next st...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App